β6 integrin induces the expression of metalloproteinase-3 and metalloproteinase-9 in colon cancer cells via ERK-ETS1 pathway

Cancer Letters

Volumn 354, Issue 2, 2014, Pages 427-437

  Gao, Huijie ^a,b   Peng, Cheng ^a,b   Liang, Benjia ^a,b   Shahbaz, Muhammad ^a,b   Liu, Song ^c   Wang, Ben ^a,b   Sun, Qi ^a,b   Niu, Zhengchuan ^a,b   Niu, Weibo ^a   Liu, Enyu ^a   Wang, Jiayong ^a   Lin, Pengfei ^a   Wang, Jian ^d   Niu, Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colon cancer; ETS1; 6 integrin

Indexed keywords

BETA6 INTEGRIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ETS1; STROMELYSIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BETA INTEGRIN; ETS1 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER CELL; CELL INVASION; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; INTERNALIZATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; AMINO ACID SEQUENCE; BIOSYNTHESIS; COLON TUMOR; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HT 29 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION;

AMINO ACID SEQUENCE; COLONIC NEOPLASMS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; INTEGRIN BETA CHAINS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, MESSENGER; UP-REGULATION;

EID: 84907976823     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.08.017     Document Type: Article

References (43)

1. Shike M., Winawer S.J., Greenwald P.H., Bloch A., Hill M.J., Swaroop S.V. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull. World Health Organ 1990, 68:377-385.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
3. Song X., Zhao Z., Barber B., Gregory C., Schutt D., Gao S. Characterizing medical care by disease phase in metastatic colorectal cancer. Am. J. Manag. Care 2011, 17(Suppl. 5 Developing):Sp20-Sp25.
4. Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am 2001, 10:383-392. x.
5. Sengupta N., MacDonald T.T. The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiology (Bethesda) 2007, 22:401-409.
6. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284:67-68.
7. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011, 278:16-27.
8. Clark I.M., Swingler T.E., Sampieri C.L., Edwards D.R. The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol 2008, 40:1362-1378.
9. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
10. Harburger D.S., Calderwood D.A. Integrin signalling at a glance. J. Cell Sci 2009, 122:159-163.
11. Bandyopadhyay A., Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr. Drug Targets 2009, 10:645-652.
12. Niu J., Gu X., Turton J., Meldrum C., Howard E.W., Agrez M. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem. Biophys. Res. Commun 1998, 249:287-291.
13. Niu J., Gu X., Ahmed N., Andrews S., Turton J., Bates R., et al. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int. J. Cancer 2001, 92:40-48.
14. Yang G.Y., Xu K.S., Pan Z.Q., Zhang Z.Y., Mi Y.T., Wang J.S., et al. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 2008, 99:879-887.
15. Zhao-Yang Z., Ke-Sen X., Qing-Si H., Wei-Bo N., Jia-Yong W., Yue-Tang M., et al. Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett 2008, 266:209-215.
16. Zhang Z.Y., Xu K.S., Wang J.S., Yang G.Y., Wang W., Wang J.Y., et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin. Oncol. (R. Coll. Radiol.) 2008, 20:61-66.
17. Peng C., Liu X., Liu E., Xu K., Niu W., Chen R., et al. Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway. Cancer Sci 2009, 100:2302-2308.
18. Wang B., Wang W., Niu W., Liu E., Liu X., Wang J., et al. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin alphavbeta6. Carcinogenesis 2014, 35:282-291.
19. Liu S., Liang B., Gao H., Zhang F., Wang B., Dong X., et al. Integrin alphavbeta6 as a novel marker for diagnosis and metastatic potential of thyroid carcinoma. Head Neck Oncol 2013, 5:7.
20. Zhao R., Liu X.Q., Wu X.P., Liu Y.F., Zhang Z.Y., Yang G.Y., et al. Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. Cancer Lett 2010, 287:150-156.
21. Niu W., Liu X., Zhang Z., Xu K., Chen R., Liu E., et al. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. Anticancer Res 2010, 30:135-142.
22. Wang J., Wu J., Hong J., Chen R., Xu K., Niu W., et al. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin alphavbeta6. Cancer Lett 2011, 311:38-47.
23. Niu J., Dorahy D.J., Gu X., Scott R.J., Draganic B., Ahmed N., et al. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit. Int. J. Cancer 2002, 99:529-537.
24. Gu X., Niu J., Dorahy D.J., Scott R., Agrez M.V. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. Br. J. Cancer 2002, 87:348-351.
25. Ahmed N., Niu J., Dorahy D.J., Gu X., Andrews S., Meldrum C.J., et al. Direct integrin alphavbeta6-ERK binding: implications for tumour growth. Oncogene 2002, 21:1370-1380.
26. Ghosh S., Basu M., Roy S.S. ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3. J. Biol. Chem 2012, 287:15001-15015.
27. Overall C.M., Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2002, 2:657-672.
28. Sementchenko V.I., Watson D.K. Ets target genes: past, present and future. Oncogene 2000, 19:6533-6548.
29. Kar A., Gutierrez-Hartmann A. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit. Rev. Biochem. Mol. Biol 2013, 48:522-543.
30. Vournakis J.N., Eldridge J., Demcheva M., Muise-Helmericks R.C. Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1. J. Vasc. Res 2008, 45:222-232.
31. Znoyko I., Trojanowska M., Reuben A. Collagen binding alpha2beta1 and alpha1beta1 integrins play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts. Mol. Cell. Biochem 2006, 282:89-99.
32. Xu H., Chen X., Huang J., Deng W., Zhong Q., Yue C., et al. Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening. Biochem. Biophys. Res. Commun 2013, 436:96-103.
33. Yu J.Y., DeRuiter S.L., Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. U.S.A. 2002, 99:6047-6052.
34. Agrez M., Chen A., Cone R.I., Pytela R., Sheppard D. The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain. J. Cell Biol 1994, 127:547-556.
35. Liu S., Wang J., Niu W., Liu E., Peng C., Lin P., et al. The beta6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer. Cancer Lett 2013, 328:325-334.
36. Wang J., Zhang Z., Xu K., Sun X., Yang G., Niu W., et al. Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway. Int. J. Cancer 2008, 123:1311-1317.
37. Zucker S., Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-117.
38. Qin D., Li K., Qu J., Wang S., Zou C., Sheng Y., et al. HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1. Arch. Virol 2013, 158:1773-1781.
39. Li H.X., Zheng J.H., Fan H.X., Li H.P., Gao Z.X., Chen D. Expression of alphavbeta6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J. Oral Pathol. Med 2013, 42:547-556.
40. Al-Hazmi N., Thomas G.J., Speight P.M., Whawell S.A. The 120 kDa cell-binding fragment of fibronectin up-regulates migration of alphavbeta6-expressing cells by increasing matrix metalloproteinase-2 and -9 secretion. Eur. J. Oral Sci 2007, 115:454-458.
41. Dittmer J. The biology of the Ets1 proto-oncogene. Mol. Cancer 2003, 2:29.
42. Chapnick D.A., Warner L., Bernet J., Rao T., Liu X. Partners in crime: the TGFbeta and MAPK pathways in cancer progression. Cell Biosci 2011, 1:42.
43. Milkiewicz M., Uchida C., Gee E., Fudalewski T., Haas T.L. Shear stress-induced Ets-1 modulates protease inhibitor expression in microvascular endothelial cells. J. Cell. Physiol 2008, 217:502-510.